


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.32%
+1.99%
+2.67%
+0.07%
IOVA
Iovance Biotherapeutics
$3.78
Risk Analysis

Earnings are forecast to decrease
Technical Indicators

5+ Days Up
IOVA Price Performance
$2.98 (+26.85%)
$2.44 (+54.92%)
$2.17 (+74.19%)
$3.9 (-3.08%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Eps growth
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
Earnings are forecast to decrease
IOVA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
IOVA Street Sentiment is extremely bullish and have positive views on the near-term outlook
IOVA has Low risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Dec 18, 2025
Reiterate
Overweight
Barclays
Nov 25, 2025
Reiterate
Overweight
Barclays
Nov 07, 2025
Reiterate
Buy
Chardan Capital
What is IOVA current stock price?
What are IOVA stock strengths?
What is IOVA Risk Level?
What is IOVA market cap and volume?
What is IOVA current Stock IQ?
Should I buy IOVA stock right now?
Is IOVA a Strong Buy right now?
What does a 'Strong Buy' rating mean for IOVA?
What does a 'Strong Sell' rating mean for IOVA?
What factors influence IOVA's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
IOVA
Iovance Biotherapeutics
Current Price
$3.78

IOVA Price Performance
$2.98 (+26.85%)
$2.44 (+54.92%)
$2.17 (+74.19%)
$3.9 (-3.08%)
IOVA Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Eps growth
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
Earnings are forecast to decrease
IOVA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
IOVA Street Sentiment is extremely bullish and have positive views on the near-term outlook
IOVA has Low risk level
Risk Indicators
Average key support and resistance price levels
Overall Wall Street Rating
IOVA Stock IQ
Stock Insights
Risk Analysis

Earnings are forecast to decrease
Technical Indicators

5+ Days Up
IOVA Latest Analysis
Iovance surges on Q4 results Amtagvi data in soft tissue sarcoma.
Today
Iovance outlines surge toward profitability with 30% revenue growth in Q4 2025 while expanding Amtagvi adoption and pipeline.
Today
Iovance Biotherapeutics GAAP EPS of -$0.18 in-line revenue of $86.71M beats by $5.7M.
Today
Iovance Biotherapeutics Highlights Strong Fourth Quarter and Full Year 2025 Results Business Achievements and Corporate Updates. ~30% Quarterly Revenue Growth Driven by Amtagvi Demand
Today
Examining the Future: Iovance Biotherapeuticss Earnings Outlook. Iovance Biotherapeutics (NASDAQ:IOVA) is preparing to release its quarterly earnings on Tuesday 2026-02-24. Here'.s a brief overview of what investors should keep in mind before the announcement.Analysts expect Iovance Biotherapeutics to report an The announcement from Iovance Biotherapeutics is eagerly anticipated with investors seeking news of surpassing estimates and favorable guidance for the next quarter.It'.s worth no
Mon Feb 23, 2026
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4). SAN CARLOS Calif. Feb. 20 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics Inc. (NASDAQ: IOVA) (Iovance or the Company) a biotechnology company focused on innovating developing and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer today announced that on February 19 2026 (the Date of Grant) the Company approved the grant of inducement stock options covering an
Fri Feb 20, 2026
Is Iovance Biotherapeutics Inc. (IOVA) One of the Best Immunotherapy Stocks to Buy According to Hedge Funds?.
Thu Feb 19, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
IOVA Stock trends
IOVA Stock performance
IOVA Stock analysis
IOVA investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.